✦ LIBER ✦

Phase I trial of DNA-hsp65 immunotherapy for advanced squamous cell carcinoma of the head and neck

✍ Scribed by Michaluart, P; Abdallah, K A; Lima, F D; Smith, R; Moysés, R A; Coelho, V; Victora, G D; Socorro-Silva, A; Volsi, E C; Zárate-Bladés, C R

Book ID: 109842539
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 216 KB
Volume: 15
Category: Article
ISSN: 0929-1903
DOI: 10.1038/cgt.2008.35

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of carboplatin and vinbla

Phase II trial of carboplatin and vinblastine in advanced squamous-cell carcinoma of the head and neck

✍ S. EL Sayed; R. P. Symonds; A. G. Robertson; J. Paul; J. McGarva 📂 Article 📅 1990 🏛 Springer 🌐 English ⚖ 217 KB

Combination chemotherapy for advanced sq

Combination chemotherapy for advanced squamous cell carcinoma of the head and neck

✍ Coker, Donald D. ;Elias, E. George ;Chretien, Paul B. ;Gray, William C. ;Coleman 📂 Article 📅 1981 🏛 Wiley (John Wiley & Sons) ⚖ 639 KB

## Abstract Fifty‐one patients (32 previously untreated, 19 previously treated) with advanced squamous cell carcinoma of the head and neck received a single course of combination chemotherapy consisting of high dose __cis__‐platinum (DDP), bleomycin (Bleo), ± high dose methotrexate (MTX). Thirty‐th

Phase II trial: concurrent radio-chemoth

Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck

✍ A. Biete Solà; J. Marruecos Querol; F. A. Calvo Manuel; E. Verger Fransoy; À. Ro 📂 Article 📅 2007 🏛 Springer Milan 🌐 Spanish ⚖ 469 KB

Phase I/II trial of weekly docetaxel and

Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck

✍ Masato Fujii; Mamoru Tsukuda; Bunsuke Satake; Akira Kubota; Akinori Kida; Naoyuk 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 428 KB

Phase II study of mitoxantrone in advanc

Phase II study of mitoxantrone in advanced squamous cell carcinoma of the head and neck

✍ Stephen D. Williams; Robert Birch; Enrique Velez-Garcia; Richard Gams 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 170 KB

A phase II study of mitoxantrone in squamous cell carcinoma of head and neck origin was conducted. Fiftythree evaluable patients were treated with this agent at a dosage of 5 mg/M2/week. The majority of patients were of high performance status. Twenty-seven patients had received previous chemotherap

Adjuvant chemotherapy for advanced head

Adjuvant chemotherapy for advanced head and neck squamous carcinoma

✍ Final report of the head; neck contracts program 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 1016 KB

To determine the efficacy of adjuvant chemotherapy in patients with advanced head and neck squamous carcinoma, the National Cancer Insitute initiated a multi-institutional, prospective randomized trial termed the Head and Neck Contracts Program. Between 1978 and 1982,462 patients with resectable Sta